Welcome to the website of EFIS
Travel Grants for IUIS 2023
The call for applications for EFIS-EJI and EFIS-ACTERIA Travel Grants to attend IUIS 2023 is now open. Full details are available here.
EFIS - Ukraine Mobility Initiative
In confirming its support for the Ukraine immunology and allergology community, EFIS has launched a special mobility scheme to assist Ukrainian students and early career researchers active in immunology and related fields who currently are unable to work as they are forced to flee the ongoing conflict or are already abroad and cannot return home. Download more information here.
EFIS Statement on Ukraine
These are truly challenging times: just as the world was beginning to taste the freedoms from restrictions imposed by a pandemic, another crisis has captured the attention and sentiments of the international community.
The European Federation of Immunological Societies (EFIS) first wishes to express its unwavering support and solidarity to the whole of Ukraine, its citizens, and all people affected by the war. Second, the unprovoked aggression of Russian Federation armed forces against a neighbouring nation demands condemnation, and EFIS joins the international community in denouncing this invasion.
At the same time, EFIS - as a federation of national European societies dedicated to the science of immunology and related fields - knows that the overwhelming majority of its community members share the principle that science and scientific collaboration are apolitical, know no borders, and help to guarantee peaceful coexistence among nations and their peoples. An integral part of that collaboration is the exchange of individuals and ideas, and EFIS will continue to dedicate its resources to nurture such exchange.
Conflicts of this kind breed too many innocent bystanders: normal citizens, organisations, entire communities with like-minded aims that have nothing to do with the crisis at hand. And science is one of these bystanders that must respond with the resources at its disposal.
NEWS FROM OUR OFFICIAL JOURNALS
Sensing context: Inhibitory receptors on non‐hematopoietic cells
Immunomodulation of neutrophil granulocyte functions by bacterial polyphosphates
Bystander activation of tissue‐resident memory CD4 T cells: Getting by with a little help from unfamiliar T‐cell friends
Cytokines enhance human Vγ9Vδ2 T cell TCR‐dependent and independent effector functions
Tissue‐specific antigen‐presenting cells contribute to distinct phenotypes of allergy
Acidity‐mediated induction of FoxP3+ regulatory T cells
Mast cells in type 2 skin inflammation – maintenance and function
The innate immune response in tauopathies
Immunoregulation of asthma by type2 cytokine therapies – treatments for all ages?
Eomesodermin‐expressing type 1 regulatory (EOMES+Tr1)‐like T cells: Basic biology and role in immune‐mediated diseases
Mechanistic insights into immunopathogenesis of murine cerebral malaria: Cues from “young” C57BL/6J and BALB/c mice
Monocyte chemokine receptors as therapeutic targets in cardiovascular diseases
CD73 in glioblastoma: Where are we now and what are the future directions?
Filarial infections compromise influenza vaccination efficacy: Lessons from the mouse
Asthma, obesity, and microbiota: A complex immunological interaction
IgD−CD27− double negative (DN) B cells: Origins and functions in health and disease
Proinflammatory S100A9 stimulates TLR4/NF-κB signaling pathways causing enhanced phagocytic capacity of microglial cells
Serum interleukin-38 and -41 levels as candidate biomarkers in male infertility
Deciphering prognostic value of CD22 and its contribution to suppression of proinflammatory cytokines production in patients with IgA nephropathy
TIPE-2 ameliorates inflammatory bowel disease in mice via inhibiting STAT3 and NF-kB activation